Biora Therapeutics (NASDAQ:BIOR) short interest has risen to more than 243%. More than double the company’s float...
Biora Therapeutics
Biora Therapeutics (NASDAQ:BIOR), formerly known as PROG stock was up more than +182% in the first week...